mda-7/IL-24, A Novel Cancer Selective Apoptosis Inducing Cytokine Gene: From the Laboratory into the Clinic

An obstacle to effective gene-based cancer therapies is the limited number of cancer-specific growth suppressing and apoptosis-inducing genes. Using a differentiation induction subtraction hybridization (DISH) approach with human melanoma cells, melanoma differentiation associated (mda) genes were isolated that display elevated expression as a function of irreversible growth arrest, cancer reversion and terminal differentiation. This screening paradigm resulted in the cloning of mda-7 in the context of terminal differentiation of human melanoma cells. Based on its structure, chromosomal location, sequence homology and cytokine-like properties, mda-7 has now been renamed IL-24 and classified as a member of the expanding IL-10 cytokine gene family. Expression of mda-7/IL-24 inversely correlates with melanoma progression and administration of mda-7/IL-24 by means of a replication incompetent adenovirus, Ad.mda-7, results in growth suppression and apoptosis in melanoma cells as well as in a broad-spectrum of additional cancer cell types. In contrast, Ad.mda-7 does not elicit deleterious effects in normal cells, including those of epithelial, fibroblast, astrocyte, melanocyte or endothelial origin. Based on these distinctive properties and anti-tumor and anti-angiogenic activities in human tumor xenograft animal models, mda-7/IL-24 has now entered the clinical arena. A Phase I/II clinical trial in patients with advanced carcinomas involving intratumoral administration of mda-7/IL-24 [using a replication incompetent adenovirus; ING241 (Ad.mda-7)] has documented that this gene is safe and well tolerated by patients and a single virus injection elicits apoptosis in a majority of the tumor. Current data suggests that mda-7/IL-24 may function as a dual-acting cytokine in which its normal physiological functions may be related to specific aspects of the immune system and over-expression culminates in cancer-specific apoptosis. This review will provide a prospectus of our current understanding of mda-7/IL-24.

[1]  P. Fisher,et al.  Differentiation therapy of human cancer: basic science and clinical applications. , 2001, Pharmacology & therapeutics.

[2]  J. Minna,et al.  Targeted therapies for killing tumor cells , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[3]  N. Goldstein,et al.  Identification and temporal expression pattern of genes modulated during irreversible growth arrest and terminal differentiation in human melanoma cells , 1999, Oncogene.

[4]  M. Bar‐eli,et al.  Regulation of tumor growth and metastasis by interleukin-10: the melanoma experience. , 1999, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[5]  J. Roth,et al.  Melanoma Differentiation Associated Gene-7 (mda-7): A Novel Anti-Tumor Gene for Cancer Gene Therapy , 2001, Molecular medicine.

[6]  R. Ramesh,et al.  Melanoma differentiation-associated gene 7/interleukin (IL)-24 is a novel ligand that regulates angiogenesis via the IL-22 receptor. , 2003, Cancer research.

[7]  T. Shuin,et al.  Frequent administration of angiogenesis inhibitor TNP-470 (AGM-1470) at an optimal biological dose inhibits tumor growth and metastasis of metastatic human transitional cell carcinoma in the urinary bladder. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[8]  Suyun Huang,et al.  Synergistic therapy of human ovarian carcinoma implanted orthotopically in nude mice by optimal biological dose of pegylated interferon alpha combined with paclitaxel. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[9]  P. Fisher,et al.  Restoring apoptosis as a strategy for cancer gene therapy: focus on p53 and mda-7. , 2003, Seminars in cancer biology.

[10]  Z. Su,et al.  The melanoma differentiation-associated gene mda-6, which encodes the cyclin-dependent kinase inhibitor p21, is differentially expressed during growth, differentiation and progression in human melanoma cells. , 1995, Oncogene.

[11]  J. Roth,et al.  Adenovirus-mediated mda-7 gene expression radiosensitizes non-small cell lung cancer cells via TP53-independent mechanisms. , 2002, Molecular therapy : the journal of the American Society of Gene Therapy.

[12]  Stephen G Swisher,et al.  Adenoviral transfer of the melanoma differentiation-associated gene 7 (mda7) induces apoptosis of lung cancer cells via up-regulation of the double-stranded RNA-dependent protein kinase (PKR). , 2002, Cancer research.

[13]  Rahul Gopalkrishnan INGN-241. Introgen. , 2002, Current opinion in investigational drugs.

[14]  D. Conklin,et al.  Interleukin 20 Discovery, Receptor Identification, and Role in Epidermal Function , 2001, Cell.

[15]  R. Scott,et al.  Differentiation, differentiation/gene therapy and cancer. , 1997, Pharmacology & therapeutics.

[16]  I Que,et al.  Endostatin inhibits VEGF‐induced endothelial cell migration and tumor growth independently of zinc binding , 1999, The EMBO journal.

[17]  D. Lejeune,et al.  Cutting Edge: STAT Activation By IL-19, IL-20 and mda-7 Through IL-20 Receptor Complexes of Two Types1 , 2001, The Journal of Immunology.

[18]  J. Roth,et al.  Tumor-suppressive effects by adenovirus-mediated mda-7 gene transfer in non-small cell lung cancer cell in vitro , 2000, Gene Therapy.

[19]  Z. Su,et al.  Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53. , 1994, Oncogene.

[20]  L. Broemeling,et al.  Loss of MDA-7 expression with progression of melanoma. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  P. Fisher,et al.  mda-7 (IL-24) Inhibits Growth and Enhances Radiosensitivity of Glioma Cells In Vitro via JNK Signaling , 2003, Cancer biology & therapy.

[22]  H. Jiang,et al.  Melanoma differentiation associated gene-9, mda-9, is a human gamma interferon responsive gene. , 1998, Gene.

[23]  P. Fisher,et al.  Cytokine and tumor cell apoptosis inducing activity of mda-7/IL-24. , 2004, International immunopharmacology.

[24]  S. Pestka,et al.  Genomic structure, chromosomal localization and expression profile of a novel melanoma differentiation associated (mda-7) gene with cancer specific growth suppressing and apoptosis inducing properties , 2001, Oncogene.

[25]  Z. Su,et al.  Mda-7, a novel melanoma differentiation associated gene with promise for cancer gene therapy. , 2000, Advances in experimental medicine and biology.

[26]  K. Madden,et al.  Interleukins 19, 20, and 24 Signal through Two Distinct Receptor Complexes , 2002, The Journal of Biological Chemistry.

[27]  M. Retter,et al.  The Protein Product of the Tumor Suppressor Gene, Melanoma Differentiation-Associated Gene 7, Exhibits Immunostimulatory Activity and Is Designated IL-241 , 2002, The Journal of Immunology.

[28]  L. Broemeling,et al.  Negative association of melanoma differentiation-associated gene (mda-7) and inducible nitric oxide synthase (iNOS) in human melanoma: MDA-7 regulates iNOS expression in melanoma cells. , 2003, Molecular cancer therapeutics.

[29]  Paul B. Fisher,et al.  mda-5: An interferon-inducible putative RNA helicase with double-stranded RNA-dependent ATPase activity and melanoma growth-suppressive properties , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[30]  R. DePinho,et al.  Pancreatic cancer biology and genetics , 2002, Nature Reviews Cancer.

[31]  Z. Su,et al.  Subtraction hybridization identifies a novel melanoma differentiation associated gene, mda-7, modulated during human melanoma differentiation, growth and progression. , 1995, Oncogene.

[32]  P. Fisher,et al.  Suppression of human ribosomal protein L23A expression during cell growth inhibition by interferon-β , 1997, Oncogene.

[33]  M. Tucker,et al.  Melanoma etiology: where are we? , 2003, Oncogene.

[34]  F. Rathjen,et al.  The Neural Cell Recognition Molecule Neurofascin Interacts with Syntenin-1 but Not with Syntenin-2, Both of Which Reveal Self-associating Activity* , 2001, The Journal of Biological Chemistry.

[35]  J. Gu,et al.  Induction of p53-regulated genes and tumor regression in lung cancer patients after intratumoral delivery of adenoviral p53 (INGN 201) and radiation therapy. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[36]  S. Kotenko,et al.  Interleukin 24 (MDA-7/MOB-5) Signals through Two Heterodimeric Receptors, IL-22R1/IL-20R2 and IL-20R1/IL-20R2* , 2002, The Journal of Biological Chemistry.

[37]  A. Sahin,et al.  Down‐regulated melanoma differentiation associated gene (mda‐7) expression in human melanomas , 2001, International journal of cancer.

[38]  Z. Su,et al.  The cancer growth suppressor gene mda-7 selectively induces apoptosis in human breast cancer cells and inhibits tumor growth in nude mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[39]  P. Fisher,et al.  The cancer growth suppressing gene mda-7 induces apoptosis selectively in human melanoma cells , 2002, Oncogene.

[40]  P. Fisher,et al.  mda-7 (IL-24) mediates selective apoptosis in human melanoma cells by inducing the coordinated overexpression of the GADD family of genes by means of p38 MAPK , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[41]  M. Kuwano,et al.  ZD1839 (Iressa) induces antiangiogenic effects through inhibition of epidermal growth factor receptor tyrosine kinase. , 2002, Cancer research.

[42]  C. D. Krause,et al.  Interleukin-10 and related cytokines and receptors. , 2004, Annual review of immunology.

[43]  K. Asadullah,et al.  Cutting Edge: Immune Cells as Sources and Targets of the IL-10 Family Members? , 2002, The Journal of Immunology.

[44]  S. Kotenko The family of IL-10-related cytokines and their receptors: related, but to what extent? , 2002, Cytokine & growth factor reviews.

[45]  P. Fisher,et al.  mda-7 (IL-24): signaling and functional roles. , 2002, BioTechniques.

[46]  P. Fisher,et al.  Melanoma differentiation associated gene-7, mda-7/IL-24, selectively induces growth suppression, apoptosis and radiosensitization in malignant gliomas in a p53-independent manner , 2003, Oncogene.

[47]  S. Pestka,et al.  MDA-7/IL-24: novel cancer growth suppressing and apoptosis inducing cytokine. , 2003, Cytokine & growth factor reviews.

[48]  Z. Su,et al.  The melanoma differentiation associated gene mda-7 suppresses cancer cell growth. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[49]  H. Jiang,et al.  RaSH, a rapid subtraction hybridization approach for identifying and cloning differentially expressed genes. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[50]  S. Pestka,et al.  Mda‐7/IL‐24 induces apoptosis of diverse cancer cell lines through JAK/STAT‐independent pathways , 2003, Journal of cellular physiology.

[51]  P. Hersey Advances in management of melanoma. , 1999, Australian and New Zealand journal of medicine.

[52]  S. Pestka,et al.  Effects of combined treatment with interferon and mezerein on melanogenesis and growth in human melanoma cells. , 1985, Journal of interferon research.

[53]  D. McConkey,et al.  Adenoviral Transfer of mda-7 Leads to BAX Up-regulation and Apoptosis in Mesothelioma Cells, and is Abrogated by Over-expression of BCL-XL , 2002, Molecular medicine.

[54]  O. Volpert,et al.  Maspin is an angiogenesis inhibitor , 2000, Nature Medicine.

[55]  A. Buzaid,et al.  Inducible nitric oxide synthase and nitrotyrosine in human metastatic melanoma tumors correlate with poor survival. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[56]  W. Linehan,et al.  MDA-7 (interleukin-24) inhibits the proliferation of renal carcinoma cells and interacts with free radicals to promote cell death and loss of reproductive capacity. , 2003, Molecular cancer therapeutics.

[57]  V. Srikantan,et al.  Differential effects of interferon gamma and alpha on in vitro model of angiogenesis , 1991, Journal of cellular physiology.

[58]  Z. Su,et al.  A combinatorial approach for selectively inducing programmed cell death in human pancreatic cancer cells , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[59]  K. Hunt,et al.  Adenoviral melanoma differentiation-associated gene 7 induces apoptosis in lung cancer cells through mitochondrial permeability transition-independent cytochrome c release. , 2003, The Journal of thoracic and cardiovascular surgery.

[60]  J. Roth,et al.  Inhibition of human lung cancer growth following adenovirus-mediated mda-7 gene expression in vivo , 2002, Oncogene.

[61]  L. Sachs Control of normal cell differentiation and the phenotypic reversion of malignancy in myeloid leukaemia , 1978, Nature.

[62]  D. Gemsa,et al.  IL-24 is expressed by rat and human macrophages. , 2002, Immunobiology.

[63]  P. Fisher,et al.  Bcl-2 and Bcl-xL differentially protect human prostate cancer cells from induction of apoptosis by melanoma differentiation associated gene-7, mda-7/IL-24 , 2003, Oncogene.

[64]  N. Goldstein,et al.  Differentiation induction subtraction hybridization (DISH): a strategy for cloning genes displaying differential expression during growth arrest and terminal differentiation. , 1999, Gene.

[65]  J. Baselga,et al.  A role for a PDZ protein in the early secretory pathway for the targeting of proTGF-alpha to the cell surface. , 1999, Molecular cell.

[66]  Giovanni Parmigiani,et al.  Relationships and differentially expressed genes among pancreatic cancers examined by large-scale serial analysis of gene expression. , 2002, Cancer research.

[67]  S. Pestka,et al.  Cloning and characterization of human ubiquitin-processing protease-43 from terminally differentiated human melanoma cells using a rapid subtraction hybridization protocol RaSH. , 2001, Gene.